Materialise Q3: medical grows 9.7% while higher R&D spending trims profit
Materialise reported third-quarter 2026 revenue of €67.7 million, up 2.1%, or 4.9% after removing the divested RapidFit and Eyewear businesses. Medical drove the growth and series production in manufacturing rose, but net profit fell to €1.38 million as R&D spending climbed and software sales weakened. The full-year guidance was left unchanged.